Bodyweight gain induced by psychotropic drugs - Incidence, mechanisms and management

被引:52
作者
Ackerman, S
Nolan, LJ
机构
[1] St Lukes Roosevelt Hosp Ctr, New York, NY 10025 USA
[2] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA
关键词
D O I
10.2165/00023210-199809020-00005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Some bodyweight gain is common with many of the psychotropic drugs frequently used to treat psychiatric disorders, Although in most instances the gain is not clinically significant, that induced by some drugs, such as lithium and atypical antipsychotics, can be quite large and clinically significant. Individual patients may not wish to continue with medications that increase bodyweight, even by amounts that have no significant effect on health, The true prevalence of bodyweight gain is often difficult to discern because of confounding factors within studies that have assessed this effect, such as the simultaneous use of multiple drugs and the absence of data on starting bodyweight. Risk factors for weight increase have not yet been well characterised, although in general the potential for drug-induced bodyweight gain is greatest in individuals with a past and/or family history of obesity. Little is currently known about the mechanisms of bodyweight gain that is induced by any drug.
引用
收藏
页码:135 / 151
页数:17
相关论文
共 95 条
  • [71] POTTER WZ, 1991, NEW ENGL J MED, V325, P633
  • [72] COMPARATIVE TOLERABILITY PROFILES OF THE NEWER VERSUS OLDER ANTIDEPRESSANTS
    RUDORFER, MV
    MANJI, HK
    POTTER, WZ
    [J]. DRUG SAFETY, 1994, 10 (01) : 18 - 46
  • [73] SEDMAN G, 1973, BRIT J PSYCHIAT, V23, P69
  • [74] JUVENILE MYOCLONIC EPILEPSY - DIAGNOSIS, MANAGEMENT AND OUTCOME
    SHARPE, C
    BUCHANAN, N
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1995, 162 (03) : 133 - 134
  • [75] ADVERSE-EFFECTS OF 2 LONG-ACTING DEPOT ANTIPSYCHOTIC-DRUGS
    SHOOKA, A
    ALHADDAD, MK
    MATHUR, V
    [J]. DRUG INVESTIGATION, 1993, 6 (02): : 110 - 113
  • [76] SHOPSIN B, 1972, ARCH GEN PSYCHIAT, V26, P566
  • [77] PREVALENCE OF OBESITY IN PATIENTS RECEIVING DEPOT ANTIPSYCHOTICS
    SILVERSTONE, T
    SMITH, G
    GOODALL, E
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1988, 153 : 214 - 217
  • [78] WEIGHT-GAIN ASSOCIATED WITH NEUROLEPTIC MEDICATION - A REVIEW
    STANTON, JM
    [J]. SCHIZOPHRENIA BULLETIN, 1995, 21 (03) : 463 - 472
  • [79] 6-YEAR FOLLOW-UP-STUDY ON THE EFFICACY AND SAFETY OF VIGABATRIN IN PATIENTS WITH EPILEPSY
    TARTARA, A
    MANNI, R
    GALIMBERTI, CA
    MORINI, R
    MUMFORD, JP
    IUDICE, A
    PERUCCA, E
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1992, 86 (03): : 247 - 251
  • [80] TEICHER MH, 1989, PSYCHOPHARMACOL BULL, V25, P535